Mounjaro vs Wegovy vs Ozempic Results UK | Cured Pharmacy

Clinically Proven UK Registered Pharmacy

Mounjaro vs Wegovy vs Ozempic: Weight Loss Results

UK-registered clinical team
Confidential and secure
No GP visit needed
Fast and discreet delivery
Start Your Free Consultation

Takes less than 2 minutes to complete 100% online

Weightlossnew £10 off for new customers
Genuine Products
UK-licensed only
Fast Delivery
Next-day available
Expert Advice
UK pharmacists
Woman using Cured Pharmacy online consultation for weight loss treatment
£145.00 From £135.00 £10 discount using discount code Weightlossnew
LIVE PRICING

Our Pricing

Pricing Disclaimer: Prices on some pages may not be up to date — the live pricing table below and pricing shown during consultation are official current prices and take precedence over any other figures on the site.

Mounjaro (Tirzepatide)
Weeks 1–4

2.5mg

1 pen • 4 Weeks

£145 £135.00

£36.25 / Per Week

Your starting dose – designed to help your body adjust gently to treatment

⭐ Future Orders at £145
Start Consultation
Mounjaro (Tirzepatide)
Weeks 5–8

5mg

1 pen • 4 Weeks

£179 £169.00

£44.75 / Per Week

First step up – builds on your progress as your body adapts to treatment

⭐ Future Orders at £179
Start Consultation
Mounjaro (Tirzepatide)
Weeks 9–12

7.5mg

1 pen • 4 Weeks

£220 £210.00

£55.00 / Per Week

Mid-range dose – for continued progression and enhanced results

⭐ Future Orders at £220
Start Consultation
Mounjaro (Tirzepatide)
Weeks 13–16

10mg

1 pen • 4 Weeks

£245 £235.00

£61.25 / Per Week

Higher strength dose – supports significant weight loss progress

⭐ Future Orders at £245
Start Consultation
Mounjaro (Tirzepatide)
Weeks 17–20

12.5mg

1 pen • 4 Weeks

£270 £260.00

£67.50 / Per Week

Advanced dose – for patients requiring stronger therapeutic effect

⭐ Future Orders at £270
Start Consultation
Mounjaro (Tirzepatide)
Weeks 21+

15mg

1 pen • 4 Weeks

£287 £277.00

£71.75 / Per Week

Maximum dose – the highest available strength for optimal results

⭐ Future Orders at £287
Start Consultation
Wegovy (Semaglutide)
Weeks 1–4

0.25mg

1 pen • 4 Weeks

£89 £79.00

£22.25 / Per Week

Your starting dose – eases your body into treatment with minimal side effects

⭐ Future Orders at £89
Start Consultation
Wegovy (Semaglutide)
Weeks 5–8

0.5mg

1 pen • 4 Weeks

£109 £99.00

£27.25 / Per Week

First step up – continues building tolerance for long-term success

⭐ Future Orders at £109
Start Consultation
Wegovy (Semaglutide)
Weeks 9–12

1mg

1 pen • 4 Weeks

£119 £109.00

£29.75 / Per Week

Mid-range dose – where most patients start seeing meaningful results

⭐ Future Orders at £119
Start Consultation
Wegovy (Semaglutide)
Weeks 13–16

1.7mg

1 pen • 4 Weeks

£169 £159.00

£42.25 / Per Week

Higher strength – supports accelerated weight loss progress

⭐ Future Orders at £169
Start Consultation
Wegovy (Semaglutide)
Weeks 17+

2.4mg

1 pen • 4 Weeks

£199 £189.00

£49.75 / Per Week

Maximum dose – the highest available strength for optimal weight management

⭐ Future Orders at £199
Start Consultation

Mounjaro vs Wegovy vs Ozempic: Weight Loss Results

When comparing mounjaro vs wegovy vs ozempic weight loss results UK, clinical trial data shows distinct differences in efficacy, mechanism, and patient outcomes. At Cured Pharmacy, our UK-registered clinical team helps you navigate these evidence-based options with transparent pricing and expert guidance. All three medications require assessment by a UK prescriber before dispensing.

Clinical Weight Loss Results: What the Trials Show

Mounjaro (tirzepatide) demonstrated the highest average weight reduction in head-to-head comparisons. In the SURMOUNT-1 trial, participants achieved up to 22.5% total body weight loss over 72 weeks on the 15mg maintenance dose [1]. This dual GIP/GLP-1 receptor agonist mechanism appears to produce superior metabolic effects compared to single-pathway treatments.

Wegovy (semaglutide 2.4mg) showed an average 14.9% body weight reduction over 68 weeks in the STEP 1 trial [2]. Whilst lower than tirzepatide results, this still represents clinically significant weight loss for patients with obesity or overweight with comorbidities.

Ozempic (semaglutide 1mg) was originally licensed for type 2 diabetes management, not obesity treatment. Clinical trials showed approximately 6-7% body weight reduction at the 1mg dose [3]. Patients seeking weight loss are typically prescribed Wegovy, which contains the same active ingredient at a higher therapeutic dose specifically licensed for obesity management by the MHRA.

How These Medications Work Differently

Mounjaro contains tirzepatide, the first dual GIP/GLP-1 receptor agonist licensed in the UK. It activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, creating a synergistic effect on appetite regulation, insulin secretion, and energy expenditure [1].

Both Wegovy and Ozempic contain semaglutide, a selective GLP-1 receptor agonist. The key difference lies in dosing: Wegovy delivers 2.4mg weekly for weight management, whilst Ozempic provides up to 1mg weekly for diabetes control. The GLP-1 pathway slows gastric emptying, reduces appetite, and improves glycaemic control [2].

This mechanistic difference explains why tirzepatide consistently outperforms semaglutide in weight loss trials. The dual receptor activation creates broader metabolic effects, though both medication classes require gradual dose escalation to minimise gastrointestinal side effects.

Dosing Schedules and Titration

All three treatments use once-weekly subcutaneous injections with structured dose escalation. Mounjaro starts at 2.5mg weekly, increasing every four weeks up to a maximum 15mg maintenance dose. Wegovy begins at 0.25mg weekly, escalating to 2.4mg over 16-20 weeks. Your UK prescriber determines the appropriate titration schedule based on tolerability and clinical response.

Mounjaro vs Wegovy vs Ozempic: Side Effect Profiles

Gastrointestinal side effects are the most common across all three medications, typically occurring during dose escalation. In clinical trials, nausea affected 29-44% of tirzepatide users and 20-44% of semaglutide users, though symptoms generally decreased over time [1][2].

Mounjaro trials reported slightly higher rates of diarrhoea and vomiting compared to semaglutide, particularly at higher doses. However, discontinuation rates due to adverse events remained below 7% in major trials [1]. Wegovy showed similar tolerability, with most participants completing dose escalation successfully when following the prescribed titration schedule [2].

Serious side effects remain rare but require clinical awareness. Both medication classes carry warnings about potential thyroid C-cell tumours (based on rodent studies), pancreatitis risk, and gallbladder disease. Your UK prescriber will review your medical history for contraindications including personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2.

Managing Common Side Effects

Most gastrointestinal symptoms improve with dietary modifications: eating smaller portions, avoiding high-fat meals, and staying well-hydrated. If side effects persist beyond the first few weeks at a new dose, your prescriber may adjust the titration schedule or recommend symptomatic management strategies. Never increase your dose without clinical guidance.

Treatment Active Ingredient Licensed Indication Average Weight Loss Starting Price
Mounjaro Tirzepatide (dual GIP/GLP-1) Weight management Up to 22.5% over 72 weeks From £145
Wegovy Semaglutide 2.4mg (GLP-1) Weight management Average 14.9% over 68 weeks From £89
Ozempic Semaglutide 1mg (GLP-1) Type 2 diabetes Approximately 6-7% Not licensed for weight loss
Saxenda Liraglutide (GLP-1) Weight management Average 8% over 56 weeks From £68

Mounjaro vs Wegovy vs Ozempic Weight Loss Results UK: Cost Comparison

Pricing varies significantly between these treatments in the UK private market. At Cured Pharmacy, Mounjaro starts from £135.00 per month, representing competitive UK pricing with transparent costs shown before your consultation. We guarantee the lowest prices in the UK for genuine, licensed medications.

Treatment duration typically spans 12-18 months for optimal results, though some patients continue long-term weight maintenance therapy. Your total investment depends on your prescribed dose and treatment duration, which your UK prescriber determines based on clinical response and tolerability.

All three medications require ongoing prescription from a UK-registered prescriber. At Cured Pharmacy, your initial consultation is free and takes under three minutes online. Our superintendent pharmacist Tarun Kumar (GPhC 2233073) and clinical team ensure every prescription meets MHRA safety standards and clinical appropriateness criteria.

Which Treatment Is Right for You?

Clinical trial data suggests Mounjaro may be the most effective option for patients seeking maximum weight loss, particularly those with higher baseline BMI or previous treatment failures. The dual receptor mechanism consistently produced superior results across multiple SURMOUNT trials [1].

Wegovy remains an excellent first-line choice for many patients, offering proven efficacy with extensive real-world safety data. It may be particularly suitable if you have type 2 diabetes alongside obesity, as semaglutide provides excellent glycaemic control whilst promoting weight loss [2].

Ozempic is not licensed for weight management in the UK and should only be prescribed for type 2 diabetes treatment. If you're seeking weight loss specifically, your prescriber will recommend either Mounjaro or Wegovy based on your individual clinical profile, contraindications, and treatment goals.

Assessment by UK Prescribers

Your online consultation at Cured Pharmacy includes comprehensive medical history review, BMI calculation, assessment of contraindications, and evaluation of previous weight loss attempts. Our UK-registered prescribers follow NICE guidelines and MHRA licensing criteria to ensure clinical appropriateness. Treatment is only approved when clinically suitable and safe for your individual circumstances.

Starting Treatment at Cured Pharmacy

Our streamlined process makes accessing these medications simple and discreet. Complete your free online consultation in under three minutes, answering questions about your medical history, current medications, and weight loss goals. A UK-registered prescriber reviews your assessment within hours, not days.

Once approved, your medication is dispensed by our GPhC-registered pharmacy (9012511) and delivered in 100% discreet packaging. We provide full injection training materials, dose escalation schedules, and ongoing clinical support throughout your treatment journey.

You'll receive genuine UK-licensed medications only—never grey market imports or compounded alternatives. Our transparent pricing means you see the exact cost before consultation, with no hidden fees or subscription traps. If you have questions during treatment, our clinical team is available by phone on (+44) 116 4646009.

Ongoing Monitoring and Support

Weight loss medications work best alongside lifestyle modifications including balanced nutrition and regular physical activity. Your prescriber may recommend follow-up consultations every 12 weeks to assess progress, adjust dosing, and monitor for any adverse effects. Successful long-term weight management requires commitment to sustainable behavioural changes supported by pharmacotherapy.

Scientific References

  1. Jastreboff, A. M., Aronne, L. J., Ahmad, N. N., et al. (2022). Tirzepatide Once Weekly for the Treatment of Obesity. New England Journal of Medicine, 387(3), 205–216. https://doi.org/10.1056/NEJMoa2206038
  2. Wilding, J. P. H., Batterham, R. L., Calanna, S., et al. (2021). Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine, 384(11), 989–1002. https://doi.org/10.1056/NEJMoa2032183
  3. Davies, M., Pieber, T. R., Hartoft-Nielsen, M. L., et al. (2017). Effect of Oral Semaglutide Compared With Placebo and Subcutaneous Semaglutide on Glycemic Control in Patients With Type 2 Diabetes. JAMA, 318(15), 1460–1470. https://doi.org/10.1001/jama.2017.14752

Information on this page is for educational purposes only and is not medical advice. All prescription treatments require clinical assessment by a UK-registered prescriber. Always consult a qualified healthcare professional before starting any new medication. Individual weight loss results vary and depend on multiple factors including adherence to treatment, lifestyle modifications, and baseline health status. Mounjaro, Wegovy, and Ozempic are registered trademarks of their respective manufacturers.

How it Works?

Select from our recommended UK-licensed medications.

1

Choose your treatment

Step 1: Choose your treatment from Cured Pharmacy

Select safe UK treatments. Quick answers.

2

Answer quick questions

Step 2: Answer quick consultation questions

We will deliver direct to you as quickly as tomorrow.

3

Get it delivered fast

Step 3: Fast discreet delivery to your door

Start Your Assessment For Weight Loss

Start your journey to better health today.

  • Reviewed by UK-based prescribers
  • Takes under 3 minutes
  • Discreet Packaging

Start Your Journey To Better Health Today

Once you complete a short online assessment you will be able to choose your preferred treatment from safe medically approved options tailored to you.

Start My Assessment

Returning Customer?

Log in to Your Account

Faq

What are the weight loss results for Mounjaro vs Wegovy vs Ozempic in UK trials?
Clinical trials show Mounjaro achieved up to 22.5% average body weight reduction over 72 weeks, Wegovy showed 14.9% over 68 weeks, and Ozempic (licensed for diabetes, not weight loss) produced approximately 6-7% reduction at the 1mg dose. Individual results vary based on adherence, lifestyle factors, and baseline characteristics.
Which is more effective: Mounjaro or Wegovy for weight loss?
Head-to-head trial data suggests Mounjaro (tirzepatide) produces greater average weight loss than Wegovy (semaglutide), likely due to its dual GIP/GLP-1 receptor mechanism. However, both are highly effective MHRA-licensed treatments, and your UK prescriber will recommend the most appropriate option based on your individual medical profile.
Can I get Ozempic for weight loss in the UK?
Ozempic is licensed only for type 2 diabetes management in the UK, not weight loss. For obesity treatment, prescribers recommend Wegovy (same ingredient at higher dose) or Mounjaro, both specifically licensed by the MHRA for weight management in appropriate patients.
How much does Mounjaro cost compared to Wegovy at Cured Pharmacy?
Mounjaro starts from £135.00 monthly at Cured Pharmacy with transparent upfront pricing. Final costs depend on your prescribed dose determined by your UK prescriber during the free online consultation, which takes under three minutes to complete.
What are the main side effects of Mounjaro vs Wegovy vs Ozempic?
All three medications commonly cause gastrointestinal side effects including nausea, diarrhoea, and constipation, particularly during dose escalation. Mounjaro trials reported slightly higher rates at maximum doses, but discontinuation rates remained low across all treatments. Your prescriber will discuss individual risk factors during assessment.
How long does it take to see weight loss results with these medications?
Most patients notice initial weight loss within 4-8 weeks, with progressive results over 6-12 months as doses escalate to maintenance levels. Maximum weight reduction typically occurs around 72 weeks of continuous treatment combined with lifestyle modifications.
Do I need a prescription for Mounjaro, Wegovy, or Ozempic in the UK?
Yes, all three are prescription-only medications requiring clinical assessment by a UK-registered prescriber. At Cured Pharmacy, you complete a free online consultation reviewed by our clinical team, ensuring treatment is safe and appropriate for your individual circumstances before dispensing.
Can I switch from Wegovy to Mounjaro or vice versa?
Switching between GLP-1 medications is possible under prescriber guidance, though specific protocols vary based on your current dose and tolerability. Your UK prescriber will assess whether switching is clinically appropriate and provide a safe transition schedule if approved.